Table 4.

Mean exploration times (±SEM) in the sample and test phases of the object-in-place task after anisomycin or actinomycin infusions

InfusateDelayConditionExploration in sample phase (s)Exploration in test phase (s)
NovelFamiliarTotal
Anisomycin3 hVehicle74.9 ± 4.923.6 ± 2.710.0 ± 1.433.6 ± 3.4
Anisomycin66.8 ± 5.716.9 ± 2.38.9 ± 1.125.8 ± 3.0
24 hVehicle71.0 ± 6.121.7 ± 1.89.5 ± 1.331.2 ± 2.4
Anisomycin66.9 ± 3.416.6 ± 1.318.5 ± 1.535.1 ± 2.4
Actinomycin D24 hVehicle81.2 ± 4.433.8 ± 3.511.4 ± 2.245.2 ± 3.8
Actinomycin D83.3 ± 6.225.0 ± 2.129.7 ± 3.054.7 ± 2.3
  • Exploration in the test phase is presented as mean time spent exploring the novel and familiar objects separately and as total exploration.